Effect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in rats

Authors
Maryam Radahmadi
Mohammad Reza Sharifi
Masoud Amini
Mehrafarin Fesharaki
Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Morphine is related to dysregulation of serum hormone levels. In addition, addict subjects interest to sugar intake. Therefore, this study investigated the effect of co-administration of glucose with Mo on the glucoregulatory hormones and causing of diabetes mellitus in rats.
Materials and Methods: Male rats were randomly divided into four groups including, control, morphine, Morphine-Glucose and diabetes groups. Morphine was undergone through doses of 10, 20, 30, 40, 50, and 60 mg/kg, respectively on days 1, 2, 3, 4, 5, and 6. Then, dose of 60 mg/kg was used repeated for 20 extra days. The Morphine-Glucose group received the same doses of morphine plus 1 g/kg glucose per day. Diabetes was induced by intraperitoneal injection of 65 mg/kg streptozotocin. At the end of experiment, the serum insulin, glucagon, growth hormone (GH), cortisol, and glucose levels were measured. The homeostasis model assessment (HOMA) indexes concluding the HOMA-insulin resistance (HOMA-IR) and HOMA-β were evaluated.
Results: Morphine insignificantly induced a hyperglycemia condition and insulin resistance. Whereas, the beta-cell functions significantly (P < 0.05) decreased only in morphine group. The co-administration of glucose slightly increased the GH, and increased insulin and cortisol levels significantly (P < 0.05 and P < 0.01; respectively) in the Morphine-Glucose group. Furthermore, the co-administration of glucose with morphine could nearly modulate the morphine effects on body weight, glucose, and glucagon levels.
Conclusion: It is probable that the co-administration of glucose with morphine modulate the serum glucose levels by stimulating the beta-cell functions and to increase insulin secretion.

Keywords

1.
Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain 2009;25:170-5.  Back to cited text no. 1
    
2.
Guarna M, Ghelardini C, Galeotti N, Stefano GB, Bianchi E. Neurotransmitter role of endogenous morphine in CNS. Med Sci Monit 2005;11:RA190-3.  Back to cited text no. 2
    
3.
Glattard E, Muller A, Aunis D, Metz-Boutigue MH, Stefano GB, Goumon Y. Rethinking the opiate system? Morphine and morphine-6-glucuronide as new endocrine and neuroendocrine mediators. Med Sci Monit 2006;12:SR25-7.  Back to cited text no. 3
    
4.
Lin SL, Tsai RY, Shen CH, Lin FH, Wang JJ, Hsin ST, et al. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords. Pharmacol Biochem Behav 2010;96:236-45.  Back to cited text no. 4
    
5.
Radosevich PM, Williams PE, Lacy DB, McRae JR, Steiner KE, Cherrington AD, et al. Effects of morphine on glucose homeostasis in the conscious dog. J Clin Invest 1984;74:1473-80.  Back to cited text no. 5
[PUBMED]    
6.
Azod L, Rashidi M, Afkhami-Ardekani M, Kiani G, Khoshkam F. Effect of opium addiction on diabetes. Am J Drug Alcohol Abuse 2008;34:383-8.  Back to cited text no. 6
    
7.
Asgary S, Naderi G, Soghraty M, Ahmady P, Shahrezaee J. A study of plasma lipid peroxidation, lipids and blood sugar level in opium addicts compared with control group. ARYA Atheroscler 2005;1:72-4.  Back to cited text no. 7
    
8.
Król E, Krejpcio Z. Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model. Food Chem Toxicol 2010;48:2791-6.  Back to cited text no. 8
    
9.
Asgary S, Sarrafzadegan N, Naderi GA, Rozbehani R. Effect of opium addiction on new and traditional cardiovascular risk factors: Do duration of addiction and route of administration matter? Lipids Health Dis 2008;7:42-7.  Back to cited text no. 9
    
10.
Mysels DJ, Sullivan MA. The relationship between opioid and sugar intake: Review of evidence and clinical applications. J Opioid Manag 2010;6:445-52.  Back to cited text no. 10
    
11.
Akunne HC, Soliman KF. Hyperglycemic suppression of morphine withdrawal signs in the rat. Psychopharmacology (Berl) 1988;96:1-6.  Back to cited text no. 11
    
12.
Farhangkhoee H, Khan ZA, Barbin Y, Chakrabarti S. Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction. Diabetologia 2005;48:1401-10.  Back to cited text no. 12
    
13.
Hileeto D, Cukiernik M, Mukherjee S, Evans T, Barbin Y, Downey D, et al. Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium. Diabetes Metab Res Rev 2002;18:386-94.  Back to cited text no. 13
    
14.
Brillante DG, O'Sullivan AJ, Johnstone MT, Howes LG. Evidence for functional expression of vascular angiotensin II type 2 receptors in patients with insulin resistance. Diabetes Obes Metab 2008;10:143-50.  Back to cited text no. 14
    
15.
Mohiti-Ardekani J, Tarof N, Aflatonian A. Relationships between free leptin and insulin resistance in women with polycystic ovary syndrome. Iran J Reprod Med 2009;7:53-8.  Back to cited text no. 15
    
16.
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-6.  Back to cited text no. 16
    
17.
Dhatt RK, Rattan AK, Mangat HK. Effect of chronic intracerebroventricular morphine to feeding responses in male rats. Physiol Behav 1988;43:553-7.  Back to cited text no. 17
    
18.
Reed JL, Ghodse AH. Oral glucose tolerance and hormonal response in heroin-dependent males. Br Med J 1973;2:582-5.  Back to cited text no. 18
[PUBMED]    
19.
Ferenczi S, Núñez C, Pintér-Kübler B, Földes A, Martín F, Márkus VL, et al. Changes in metabolic-related variables during chronic morphine treatment. Neurochem Int 2010;57:323-30.  Back to cited text no. 19
    
20.
Sood A, Thakur VS, Karmarkar MG, Ahuja MM. Effect of chronic morphine administration on glucose tolerance and insulin binding to isolated rat adipocytes. Endocr Res 2001;27:215-21.  Back to cited text no. 20
    
21.
Sadava D, Alonso D, Hong H, Pettit-Barrett DP. Effect of methadone addiction on glucose metabolism in rats. Gen Pharmacol 1997;28:27-9.  Back to cited text no. 21
    
22.
Giugliano D. Morphine, opioid peptides, and pancreatic islet function. Diabetes Care 1984;7:92-8.  Back to cited text no. 22
[PUBMED]    
23.
Hosseini E. The effect of morphine on the serum level of insulin in adult male wistar rats. J Cell Anim Biol 2011;12:275-8.  Back to cited text no. 23
    
24.
Vescovi PP, Pezzarossa A, Ceresini G, Rastelli G, Valenti G, Gerra G. Effects of dopamine receptor stimulation on opiate-induced modifications of pituitary-gonadal function. Horm Res 1985;21:155-9.  Back to cited text no. 24
[PUBMED]    
25.
Bandaru P, Shankar A. Association between plasma leptin levels and diabetes mellitus. Metab Syndr Relat Disord 2011;9:19-23.  Back to cited text no. 25
    
26.
Hermansen K. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: Studies in vitro. Endocrinology 1983;113:1149-54.  Back to cited text no. 26
[PUBMED]    
27.
Stefani MR, Nicholson GM, Gold PE. ATP-sensitive potassium channel blockade enhances spontaneous alternation performance in the rat: A potential mechanism for glucose-mediated memory enhancement. Neuroscience 1999;93:557-63.  Back to cited text no. 27
    
28.
Stefani MR, Gold PE. Intrahippocampal infusions of k-atp channel modulators influence spontaneous alternation performance: Relationships to acetylcholine release in the hippocampus. J Neurosci 2001;21:609-14.  Back to cited text no. 28
    
29.
Vuong C, Van Uum SH, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010;31:98-132.  Back to cited text no. 29
    
30.
Anghel A, Jamieson CA, Ren X, Young J, Porche R, Ozigbo E, et al. Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake. Neuroscience 2010;167:554-66.  Back to cited text no. 30
    
31.
George JT, Millar RP, Anderson RA. Hypothesis: Kisspeptin mediates male hypogonadism in obesity and type 2 diabetes. Neuroendocrinology 2010;91:302-7.  Back to cited text no. 31
    
32.
Fujikawa T, Chuang JC, Sakata I, Ramadori G, Coppari R. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci U S A 2010;107:17391-6.  Back to cited text no. 32
    
33.
Bhansali A, Velayutham P, Sialy R, Sethi B. Effect of opiates on growth hormone secretion in acromegaly. Horm Metab Res 2005;37:425-7.  Back to cited text no. 33
    
34.
Reid RL, Hoff JD, Yen SS, Li CH. Effects of exogenous beta h-endorphin on pituitary hormone secretion and its disappearance rate in normal human subjects. J Clin Endocrinol Metab 1981;52:1179-84.  Back to cited text no. 34
[PUBMED]    
35.
Bossone CA, Hannon JP. Metabolic actions of morphine in conscious chronically instrumented pigs. Am J Physiol 1991;260(6 Pt 2):R1051-7.  Back to cited text no. 35
    
36.
Stubbs WA, Delitala G, Jones A, Jeffcoate WJ, Edwards CR, Ratter SJ, et al. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 1978;2:1225-7.  Back to cited text no. 36
[PUBMED]    
37.
Levine AS, Grace M, Billington CJ, Gosnell BA, Krahn DD, Brown DM, et al. Effect of morphine and nalmefene on energy balance in diabetic and non-diabetic rats. Pharmacol Biochem Behav 1988;29:495-500.  Back to cited text no. 37
    
38.
Busiguina S, Argente J, García-Segura LM, Chowen JA. Anatomically specific changes in the expression of somatostatin, growth hormone-releasing hormone and growth hormone receptor mRNA in diabetic rats. J Neuroendocrinol 2000;12:29-39.  Back to cited text no. 38
    
Advanced Biomedical Research
Volume 2016, February
February 2016
Pages 1-7